Navigation Links
Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
Date:8/11/2008

roy the tumor and the tumor blood vessels. Bavituximab currently is in two separate Phase II combination therapy trials for the treatment of advanced breast cancer and a Phase II combination therapy trial for the treatment of non-small cell lung cancer. Peregrine recently reported that a Phase II trial assessing the combination of bavituximab and docetaxel in patients with metastatic breast cancer had achieved the pre-specified Stage A primary efficacy endpoint needed to expand the trial to the second stage. A Phase I bavituximab monotherapy trial in advanced solid cancers is also continuing.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (http://www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at http://www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to, the risk that the company will experience delays or difficulties in enrolling patients in the study, the risk that th
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
2. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
3. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
4. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
5. Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV
6. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
7. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
8. Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV
9. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
10. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
11. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... April 21, 2015   iRhythm Technologies, Inc. , a ... of cardiac care, announced today that Banner Health, one ... U.S., will now be offering iRhythm,s ZIO ® ... monitoring. "At Banner Health, we are dedicated ... and services," said John Hensing , MD, Banner ...
(Date:4/21/2015)... N.J. , April 21, 2015  Navitas has ... provide a wide range of offerings for life sciences ... providing an integrated platform enabling seamless flow of data ... of the Aviator launch, Navitas worked closely with Oracle ... Hub and Oracle,s CTMS in the Cloud. ...
(Date:4/21/2015)... April 21, 2015  Edico Genome today announced ... with Intel,s Xeon processors to accelerate next generation ... enable completion of primary and secondary NGS analysis ... costs, streamlining data analysis in the cloud and ... big data sets, such as analysis of population-scale ...
Breaking Medicine Technology:Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring 2Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring 3Navitas Launches Aviator - Cloud Based Platforms for Oracle Solutions 2Navitas Launches Aviator - Cloud Based Platforms for Oracle Solutions 3Navitas Launches Aviator - Cloud Based Platforms for Oracle Solutions 4Edico Genome Collaborates with Intel to Overcome Big Data Bottleneck in Next-Generation Sequencing 2Edico Genome Collaborates with Intel to Overcome Big Data Bottleneck in Next-Generation Sequencing 3
(Date:4/21/2015)... 2015 The report “Dermatitis ... analysis on the therapeutic development for Dermatitis. ... identifying new targets and MOAs to produce ... TOC is available @ http://www.rnrmarketresearch.com/dermatitis-pipeline-review-h1-2015-market-report.html ... players involved in the therapeutic development for ...
(Date:4/21/2015)... April 21, 2015 QuickMedical, a ... and supplies, now represents Schiller America's ... ECGs, Stress Tests, and Vital Signs Monitors, among ... Switzerland, is a global leader in the development ... are developed in close cooperation with the world's ...
(Date:4/21/2015)... April 21, 2015 Carinsurancehints.com has released ... and explaining their impact on auto insurance prices ... increase auto insurance prices. Clients should review their insurance ... can be bought under several forms. Some of the ... , rivers can compare online rates and find the ...
(Date:4/21/2015)... California (PRWEB) April 21, 2015 On ... Movie Awards” EcoLuxe Lounge at the world famous Avalon ... of sustainable product placement in TV and film, the ... makes appearances at many awards ceremonies and festivals throughout ... top providers of eco-friendly and socially conscious products and ...
(Date:4/21/2015)... April 21, 2015 Edward Avalos, USDA ... “A.G.” Kawamura, former Secretary of the California Department of ... for the 2nd Annual GrowRIVERSIDE Conference: The Future of ... The inclusion of these nationally known experts intensifies an ... planners, farmers and others slated to speak at the ...
Breaking Medicine News(10 mins):Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4Health News:QuickMedical Launches New Product Line: Schiller America 2Health News:QuickMedical Launches New Product Line: Schiller America 3Health News:Heavily Circulated Roads Can increase Auto Insurance Costs 2Health News:Hollywood's Santana Dempsey and Choices Recovery South Bend Examine Victory over Personal Struggles 2Health News:USDA Under Secretary, former CA Agriculture Director to Address 2nd Annual “GrowRIVERSIDE” Conference in June 2Health News:USDA Under Secretary, former CA Agriculture Director to Address 2nd Annual “GrowRIVERSIDE” Conference in June 3
... order to effectively handle the situation in case of an ... to make all necessary preparation.// They are asked to appoint ... European Union would also have to look harder at immediate ... 25 countries. ,He said that their problem is ...
... of psychological stress in the expectant mother might prove ... the Johns Hopkins University and the National Institute of ... in the May/June 2006 edition of the journal Child ... daily stress during pregnancy is associated with more advanced ...
... Space Research Organization (ISRO) announced expansion of its ... hospitals in the country.// Manipal hospital in Banglore, ... Medical Foundation in Maharashtra and Madras Diabetic Research ... ,The telemedicine network, which began in 2001 ...
... its characteristic red color has been discovered to possess ... and heart attacks.// Previous studies have already established cancer ... scientists, the stickiness of platelets - the particles in ... percent when 220 volunteers had a drink containing the ...
... study appearing in the American Journal of Respiratory and Critical ... 11 had a loss in lung capacity equivalent to what ... the terror attacks. ,An average loss of 372 ... the lung's capacity. This loss is at least 10 times ...
... on Monday the major hospitals in Delhi revoked the leave ... were away from duty were recalled. // ,"The ... of Medical Sciences (AIIMS) as resident doctors are on an ... have cancelled all the leave applications and recalled the doctors ...
Cached Medicine News:Health News:Children Benefited By Moderate Maternal Stress? 2Health News:ISRO To Expand Telemedicine Network, 4 Speciality Hospitals To Be Included 2Health News:Delhi Hospitals Cancel Holidays And Recalls Doctors 2Health News:Delhi Hospitals Cancel Holidays And Recalls Doctors 3
... and Fracture Table is a mobile, ... flexible, easy to use, articulated posturing ... orthopedic procedures. Radiolucent abductor bars, wedge-shaped ... exceptional imaging capability. OrthoVision folds into ...
... Mesh Cathode of the OsteoGen™-M mesh ... a scaffolding effect designed to increase ... ends in the management of nonunions. ... particularly appropriate for high-risk patients and ...
Our products, with carefully researched design features, are tailored to making arthroscopic and ligament reconstructive surgery more reproducible, easier, quicker and safer....
... Interference Screw is indicated for graft ... and PCL reconstructions with bone-patellar tendon-bone ... The SmartScrew ACL provides easy and ... for any graft type. The unique ...
Medicine Products: